Chargement en cours...
Evaluation of tamoxifen and simvastatin as the combination therapy for the treatment of hormonal dependent breast cancer cells
Tamoxifen (TAM) is a nonsteroidal antiestrogen drug, used in the prevention and treatment of all stages of hormone-responsive breast cancer. Simvastatin (SIM), a lipid-lowering agent, has been shown to inhibit cancer cell growth. The study aimed at investigating the impact of using SIM with TAM in e...
Enregistré dans:
| Publié dans: | Toxicol Rep |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880098/ https://ncbi.nlm.nih.gov/pubmed/31788433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2019.10.016 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|